Leerink Partnrs Expects Lower Earnings for agilon health

agilon health, inc. (NYSE:AGL) – Research analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for shares of agilon health in a research note issued on Tuesday, February 25th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn ($0.03) per share for the quarter, down from their prior forecast of $0.05. The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share. Leerink Partnrs also issued estimates for agilon health’s Q2 2025 earnings at ($0.09) EPS, Q3 2025 earnings at ($0.13) EPS, Q4 2025 earnings at ($0.12) EPS, FY2025 earnings at ($0.36) EPS, Q1 2026 earnings at ($0.01) EPS, Q2 2026 earnings at ($0.01) EPS, Q3 2026 earnings at ($0.12) EPS, Q4 2026 earnings at ($0.10) EPS, FY2026 earnings at ($0.23) EPS, FY2027 earnings at ($0.15) EPS, FY2028 earnings at $0.00 EPS and FY2029 earnings at $0.12 EPS.

Other research analysts have also recently issued research reports about the company. Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a research report on Wednesday. Royal Bank of Canada increased their price objective on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a report on Wednesday. Stifel Nicolaus increased their price objective on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a report on Wednesday. Barclays dropped their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday, November 11th. Finally, TD Cowen dropped their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, agilon health has a consensus rating of “Hold” and a consensus price target of $3.95.

agilon health Stock Down 0.4 %

Shares of NYSE AGL opened at $3.35 on Friday. agilon health has a one year low of $1.50 and a one year high of $7.73. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The business’s fifty day moving average price is $2.94 and its 200-day moving average price is $3.04. The stock has a market capitalization of $1.38 billion, a PE ratio of -3.56 and a beta of 0.66.

Insider Activity

In other news, Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The shares were purchased at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the transaction, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Karen Mcloughlin acquired 25,000 shares of agilon health stock in a transaction dated Friday, December 13th. The shares were purchased at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have bought 77,500 shares of company stock worth $169,600. 3.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On agilon health

Several institutional investors and hedge funds have recently bought and sold shares of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in agilon health by 24.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company’s stock worth $1,516,000 after acquiring an additional 157,610 shares during the last quarter. Two Sigma Advisers LP grew its position in agilon health by 4,393.5% during the 4th quarter. Two Sigma Advisers LP now owns 480,800 shares of the company’s stock worth $914,000 after acquiring an additional 470,100 shares during the last quarter. Two Sigma Investments LP grew its position in agilon health by 73.7% during the 4th quarter. Two Sigma Investments LP now owns 857,867 shares of the company’s stock worth $1,630,000 after acquiring an additional 363,855 shares during the last quarter. State of Wyoming grew its position in agilon health by 89.3% during the 4th quarter. State of Wyoming now owns 122,504 shares of the company’s stock worth $233,000 after acquiring an additional 57,802 shares during the last quarter. Finally, Point72 Asset Management L.P. bought a new position in agilon health during the 4th quarter worth approximately $768,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.